ROYAL BANK OF CANADA – Regeneron Pharmaceuticals, Inc. Transaction History
ROYAL BANK OF CANADA portfolio value:
$222.88M
portfolio value
ROYAL BANK OF CANADA quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -3.88% | -13.07K shares | 23.89M | $688.87 | 323.54K |
Q2 2022 | share | Increase | +7.08% | 22.27K shares | -20.56M | $591.13 | 336.62K |
Q1 2022 | share | Increase | +13.03% | 36.23K shares | 43.91M | $698.42 | 314.35K |
Q4 2021 | share | Increase | +41.21% | 81.16K shares | 56.44M | $642.51 | 278.11K |
Q3 2021 | share | Increase | +95.33% | 96.12K shares | 62.87M | $605.18 | 196.95K |
Q2 2021 | share | Decrease | -1.10% | -1.12K shares | 8.08M | $558.54 | 100.83K |
Q1 2021 | share | Decrease | -38.33% | -63.37K shares | -31.63M | $473.14 | 101.95K |
Q4 2020 | share | Increase | +37.06% | 44.70K shares | 12.34M | $483.11 | 165.33K |
Q3 2020 | share | Increase | +11.47% | 12.41K shares | 39K | $559.78 | 120.62K |
Q2 2020 | share | Increase | +31.41% | 25.86K shares | 27.27M | $623.65 | 108.20K |
Q1 2020 | share | Increase | +17.24% | 12.10K shares | 13.83M | $488.29 | 82.34K |
Q4 2019 | share | Decrease | -31.07% | -31.65K shares | -1.89M | $375.48 | 70.23K |
Q3 2019 | share | Increase | +41.59% | 29.93K shares | 5.74M | $277.4 | 101.89K |
Q3 2019 | call | Decrease | -100.00% | -4.8K shares | -1.50M | $277.4 | 0 |
Q2 2019 | call | Increase | 0.00% | 4.8K shares | 1.50M | $313 | 4.8K |
Q2 2019 | share | Decrease | -43.02% | -54.33K shares | -29.33M | $313 | 71.96K |
Q1 2019 | share | Increase | +48.25% | 41.10K shares | 20.04M | $410.62 | 126.3K |
Q4 2018 | share | Increase | +0.60% | 512 shares | -2.39M | $373.5 | 85.19K |
Q3 2018 | share | Increase | +24.80% | 16.82K shares | 10.80M | $404.04 | 84.68K |
Q2 2018 | share | Decrease | -26.00% | -23.84K shares | -8.17M | $344.99 | 67.85K |
Q1 2018 | share | Increase | +22.05% | 16.56K shares | 3.33M | $344.36 | 91.69K |
Q4 2017 | share | Increase | +13.98% | 9.21K shares | -1.22M | $375.96 | 75.13K |
Q3 2017 | share | Decrease | -2.30% | -1.55K shares | -3.66M | $447.12 | 65.91K |
Q2 2017 | share | Increase | +4.33% | 2.80K shares | 8.07M | $491.14 | 67.46K |
Q1 2017 | call | Decrease | -100.00% | -500 shares | -184K | $387.51 | 0 |
Q1 2017 | share | Decrease | -9.84% | -7.06K shares | -1.27M | $387.51 | 64.66K |
Q4 2016 | share | Increase | +23.52% | 13.65K shares | 2.98M | $367.09 | 71.72K |
Q4 2016 | call | 0.00% | 0 shares | -17K | $367.09 | 500 | |
Q3 2016 | call | Decrease | -28.57% | -200 shares | -44K | $402.02 | 500 |
Q3 2016 | share | Increase | +9.91% | 5.23K shares | 4.89M | $402.02 | 58.06K |
Q2 2016 | put | Decrease | -100.00% | -25K shares | -9.01M | $349.23 | 0 |
Q2 2016 | call | Decrease | -97.28% | -25K shares | -9.01M | $349.23 | 700 |
Q2 2016 | share | Decrease | -17.11% | -10.90K shares | -4.52M | $349.23 | 52.82K |
Q1 2016 | put | Increase | 0.00% | 25K shares | 9.01M | $360.44 | 25K |
Q1 2016 | call | Increase | +5040.00% | 25.2K shares | 8.99M | $360.44 | 25.7K |
Q1 2016 | share | Decrease | -4.23% | -2.81K shares | -13.15M | $360.44 | 63.73K |